This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:ibd [01.18.2019] – [Serum levels of 'vitamin' D] sallieq | home:diseases:ibd [03.21.2019] – [Research] sallieq | ||
---|---|---|---|
Line 4: | Line 4: | ||
+ | < | ||
===== Introduction ===== | ===== Introduction ===== | ||
Line 33: | Line 33: | ||
* // | * // | ||
- | De Hertogh //et al// provide a [[http:// | + | De Hertogh //et al// provide a thorough review of the " |
< | < | ||
Line 180: | Line 180: | ||
"It is increasingly apparent that bacteria are playing a role in healthy development, | "It is increasingly apparent that bacteria are playing a role in healthy development, | ||
- | ===== Recent research | + | ===== Research |
+ | |||
+ | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. | ||
+ | |||
+ | In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity. | ||
Development, | Development, | ||
Line 191: | Line 195: | ||
Our results revealed that colonic epithelial cells express TLR9, a key pattern recognition receptor. Interestingly, | Our results revealed that colonic epithelial cells express TLR9, a key pattern recognition receptor. Interestingly, | ||
+ | |||
+ | ' | ||
+ | |||
+ | Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. | ||
+ | |||
+ | Butyric acid in functional constipation | ||
+ | |||
+ | Butyric acid in irritable bowel syndrome | ||
+ | | ||
+ | |||
+ | | ||
+ | |||
+ | [[https:// | ||
+ | | ||
+ | [[https:// | ||
+ | [{{: | ||
===== Patient interviews | ===== Patient interviews | ||
Line 221: | Line 241: | ||
{{tag> | {{tag> | ||
+ | |||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
- | (({{pubmed> | + | |
+ | (({{pubmed> | ||
+ | |||
broken link http:// | broken link http:// | ||
+ | another, maybe [[http:// | ||
< | < |